marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
Beam Therapeutics Balance Sheet 2011-2024 | BEAM
Annual Balance Sheet Beam Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-263 M | -53.8 M | -549 M | -153 M | -5.98 M | -146 M | -1.9 M | - | - | - | - | - | - |
Long Term Debt |
160 M | 169 M | 3.01 M | 5.29 M | 4.41 M | - | - | - | - | - | - | - | - |
Long Term Debt Current |
12.8 M | 10.4 M | 7.54 M | 4.22 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 26 M | 7.4 M | 20 K | - | - | - | - | - | - |
Total Current Liabilities |
206 M | 224 M | 213 M | 102 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
478 M | 608 M | 648 M | 206 M | 55.2 M | 33 M | 6.58 M | - | - | - | - | - | - |
Deferred Revenue |
68.7 M | 136 M | 86.3 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.19 B | -1.06 B | -768 M | -398 M | -203 M | -125 M | -9.46 M | - | - | - | - | - | - |
Total Assets |
1.46 B | 1.34 B | 1.47 B | 452 M | 156 M | 167 M | 2.4 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
436 M | 233 M | 560 M | 162 M | 37.2 M | 148 M | - | - | - | - | - | - | - |
Book Value |
981 M | 733 M | 827 M | 246 M | 101 M | 134 M | -4.18 M | - | - | - | - | - | - |
Total Shareholders Equity |
981 M | 733 M | 827 M | 246 M | -201 M | -117 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Beam Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
149 M | 153 M | 156 M | 160 M | 304 K | 875 K | 983 K | 1.15 M | 1.39 M | 1.79 M | 2.4 M | 3.01 M | 3.6 M | 4.18 M | 4.74 M | 5.29 M | 5.29 M | 5.29 M | 5.29 M | 4.41 M | 4.41 M | 4.41 M | 4.41 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
380 M | 407 M | 446 M | 478 M | 512 M | 542 M | 571 M | 608 M | 636 M | 618 M | 624 M | 648 M | 303 M | 345 M | 271 M | 206 M | 206 M | 206 M | 206 M | 55.2 M | 55.2 M | 55.2 M | 55.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
89.3 M | 84.9 M | 72.1 M | 68.7 M | 153 M | 139 M | 143 M | 136 M | 160 M | 140 M | 115 M | 86.3 M | 12.8 M | 10 M | - | 24 K | 24 K | 24 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.48 B | -1.38 B | -1.29 B | -1.19 B | -1.33 B | -1.24 B | -1.15 B | -1.06 B | -1.02 B | -909 M | -837 M | -768 M | -704 M | -675 M | -599 M | -398 M | -398 M | -398 M | -398 M | -203 M | -203 M | -203 M | -203 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
1.17 B | 1.26 B | 1.36 B | 1.46 B | 1.29 B | 1.35 B | 1.33 B | 1.34 B | 1.35 B | 1.42 B | 1.45 B | 1.47 B | 1.16 B | 893 M | 693 M | 452 M | 452 M | 452 M | 452 M | 156 M | 156 M | 156 M | 156 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
230 M | 293 M | 288 M | 436 M | 169 M | 226 M | 250 M | 233 M | 157 M | 266 M | 297 M | 560 M | 612 M | 212 M | 97.2 M | 177 M | 162 M | 162 M | 162 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 148 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
791 M | 854 M | 913 M | 981 M | 779 M | 812 M | 762 M | 733 M | 714 M | 800 M | 829 M | 827 M | 854 M | 549 M | 422 M | 246 M | 246 M | 246 M | 246 M | 101 M | 101 M | 101 M | 101 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
791 M | 854 M | 913 M | 981 M | 779 M | 812 M | 762 M | 733 M | 714 M | 800 M | 829 M | 827 M | 854 M | 549 M | 422 M | 246 M | 246 M | 246 M | 246 M | -201 M | -201 M | -201 M | -201 M | -117 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency